The Pharmaceutical Journal·4 min read·medium
Once-weekly HIV pill performs as well as daily treatment in phase III study
✦AI Summary
A phase III clinical trial has demonstrated that a once-weekly oral tablet is as effective as daily HIV treatments in maintaining viral suppression. This development could significantly improve quality of life and treatment adherence for patients.
A once-weekly tablet could maintain HIV control as well as existing daily treatment, according to the results of a phase III international study.
healthscience
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in